Session Information
Date: Wednesday, June 22, 2016
Session Title: Parkinson's disease: Cognition
Session Time: 12:00pm-1:30pm
Location: Exhibit Hall located in Hall B, Level 2
Objective: To investigate the pattern of grey matter (GM) atrophy associated with cognitive decline in PD by use of voxel-based morphometry (VBM) analysis.
Background: Loss of GM volume has been previously demonstrated in PD-patients with cognitive deficits. However, patient neuropsychological assessment with a structured battery specifically designed to assess PD-related cognitive decline has been never comprised in any previous VBM study. Parkinson’s disease-Cognitive Rating scale (PD-CRS) is a battery targeted to assess cognitive domains particularly affected in PD, including items sensitive to both fronto-subcortical and posterior-cortical dysfunction.
Methods: T1-weighted brain MRIs were obtained from 63 PD-patients with varying degrees of cognitive impairment. All patients underwent examination with PD-CRS. Prior to application PD-CRS was adapted into the Greek language. Clinical and medication data were also acquired. Structural data were analyzed with an optimized VBM protocol carried out with FSL tools. Multiple regression models were used to investigate the association of GM volume with total PD-CRS score and sub-scores, including age and educational level as covariates.The level of significance was set to 0.05 corrected for multiple comparisons.
Results: The basic patient characteristics are described in Table1.
Mean | Median | Range | |
Age (years) | 69.2 | 70 | 55-79 |
Hoehn & Yahr Stage | 2.3 | 2 | 1-4 |
Disease duration (years) | 6.9 | 5 | 1-25 |
Total levodopa equivalent dose (mg/day) | 814.4 | 609.8 | 0-2292 |
Total PD-CRS score | 71.2 | 74 | 19-126 |
Posterior-cortical PD-CRS score | 24 | 25 | 7-30 |
Frontal-subcortical PD-CRS score | 47.3 | 47 | 11-99 |
MMSE score | 26.1 | 27 | 18-30 |
Hamilton Depression Rating Scale score | 4.4 | 3 | 0-16 |
Conclusions: Degenerative changes in neural circuits linking cortical, limbic, thalamic, striatal and pallidal structures are significantly implicated in the progression of PD-related cognitive impairment. Neural correlates of changes in cognitive domains particularly affected in PD are revealed by use of disease-specific cognitive assessment instruments.
To cite this abstract in AMA style:
M. Chondrogiorgi, L.G. Astrakas, A.K. Zikou, M.I. Argyropoulou, S. Konitsiotis. Grey matter atrophy associated with the progression of cognitive decline in Parkinson’s disease (PD) [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/grey-matter-atrophy-associated-with-the-progression-of-cognitive-decline-in-parkinsons-disease-pd/. Accessed November 22, 2024.« Back to 2016 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/grey-matter-atrophy-associated-with-the-progression-of-cognitive-decline-in-parkinsons-disease-pd/